1. Início
  2. Laboratórios de Investigação Médica - LIMs

LIM/31 - Laboratório de Genética e Hematologia Molecular

O Laboratório de Genética e Hematologia Molecular é ligado ao Departamento de Clínica Médica da Faculdade de Medicina da Universidade de São Paulo (FMUSP).

Linhas de pesquisa: Genética e hematologia molecular; terapia celular e gênica; onco-hematologia; hemostasia; metabolismo lipídico.

Site oficial: http://limhc.fm.usp.br/portal/lim31-laboratorio-de-genetica-e-hematologia-molecular/

Browse

Collections in this community

Recent Submissions

  1. Data-driven, cross-disciplinary collaboration: lessons learned at the largest academic health center in Latin America during the COVID-19 pandemic

    FRONTIERS IN PUBLIC HEALTH, v.12, article ID 1369129, 15p, 2024

    Introduction The COVID-19 pandemic has prompted global research efforts to reduce infection impact, highlighting the potential of cross-disciplinary collaboration to enhance research quality and efficiency.Methods At the FMUSP-HC academic health system, we implemented innovative flow management r...

  2. EDUCATIONAL AUDIT PROCESS FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) REPORTS

    BONE MARROW TRANSPLANTATION, v.58, n.SUPP1, suppl.1, p.676-677, 2023

  3. BMT BRAZILIAN MAP: COMPARISON OF BMT MAP WITH EBMT ACTIVITY SURVEY AND ACTIVITY REPORT CIBMTR

    BONE MARROW TRANSPLANTATION, v.58, n.SUPP1, suppl.1, p.677-678, 2023

  4. Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed multiple myeloma (IKEMA): final overall survival analysis

    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, v.23, suppl.2, p.S30-S31, 2023

  5. Genetic variation in HLA genes: impact on transplant compatibility in a Brazilian admixed population

    HLA, v.101, n.4, p.361-361, 2023

  6. Safety and Efficacy of an Academic Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia Developed in Brazil: Increasing Access in a Public Health System

    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, v.23, suppl.1, p.S526-S526, 2023

  7. HLA ALLELE AND HAPLOTYPE FREQUENCIES IN SICKLE CELL DISEASE AND THALASSEMIA PATIENTS: A JOINT STUDY ON BEHALF OF EUROCORD AND SFGM-TC

    BONE MARROW TRANSPLANTATION, v.58, n.SUPP1, suppl.1, p.386-386, 2023

  8. First report of PhALLCON: A phase 3 study comparing ponatinib (pon) vs imatinib (im) in newly diagnosed patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL).

    JOURNAL OF CLINICAL ONCOLOGY, v.41, suppl.36, 2023

  9. REFINED ANALYSIS AT THE PEPTIDE-BINDING GROOVE LEVEL OF HLA AND GRAFT-VERSUS-HOST DISEASE ASSOCIATION IN PATIENTS WITH ACUTE LEUKEMIA WHO UNDERWENT UMBILICAL CORD BLOOD TRANSPLANTATION

    BONE MARROW TRANSPLANTATION, v.58, n.SUPP1, suppl.1, p.282-282, 2023

  10. High-dose chemotherapy with autologous stem cell transplant (HDCT) for patients (pts) with advanced germ-cell tumors (aGCT): Real-world evidence from a tertiary cancer center in Brazil.

    JOURNAL OF CLINICAL ONCOLOGY, v.41, suppl.6, 2023